MedPath

Assessment the Effect of omega 3 supplementation on Improving Metabolic Syndrome indices

Phase 3
Recruiting
Conditions
Metabolic syndrome.
Metabolic syndrome
E88.81
Registration Number
IRCT20190819044563N1
Lead Sponsor
Oroumia University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
90
Inclusion Criteria

Interested in attending the study who have completed and signed the informed consent form.
Metabolic syndrome according to existing criteria, including: There are 3 of the following: Waist circumference = 80 cm for women and Waist circumference = 94 cm for men, fasting blood glucose = 100 mg / dl , Systolic blood pressure = 130 and diastolic blood pressure above = 85 , mm Hg, HDL less than 50 mg / dL for women and less than 40 mg / dL for men and triglycerides; 150 mg / dL and drug administration for triglycerides Blood glyceride, cholesterol and LDL (including statins, etc.).
With ischemic heart disease.

Exclusion Criteria

Mental, emotional, cognitive, or any disorders that may prevent a person from participating in this study.
People who have certain dietary restrictions and follow a specific diet.
autoimmune diseases (corticosteroids), cancer
alcohol consumption
Pregnancy
Breastfeeding
Infectious Diseases
Chronic Kidney Disease
Liver disease
Food intolerance and sensitivity to fish
Drug abuse
Anticoagulants such as warfarin
Changes in the level of physical activity during the study
People taking Omega-3 supplements
Consume more than one serving of fish per week
Omega-3 sensitivity cases

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath